Patent suit over ticagrelor products settled between parties. Joint application under Order XXIII Rule 3 CPC for consent decree was allowed; suit decreed in terms of the settlement and defendants' counter claims were dismissed as withdrawn.
This page shows the compact analysis of this judgement. The full analysis — procedural history, issue-by-issue holdings with ratio and obiter, advocates, and paragraph-level evidence for every claim — is being added to the record in batches and will appear here when this judgement has been through it.
$~30
ASTRAZENECA AB & ANR .....Plaintiffs Through: Mr. Pravin Anand, Ms. Vaishali R Mittal, Mr. Siddhant Chamola, Mr. Shivang Sharma and Mr. Gursimran Singh, Advs.
versus
T RAO & ANR .....Defendants Through: Mr. Siddhant Goel, Adv. for defendants.
CORAM: HON'BLE MR. JUSTICE SAURABH BANERJEE
O R D E R
% 15.05.2025
I.A. 12450/2025 ( Order XXIII Rule 3 of the CPC )
b) The Defendants further agree to withdraw the Counter Claims CC(COMM)-24/2019, CC(COMM)-25/2019, CC(COMM)-26/2019 pending before this Hon'ble Court.
This is a digitally signed order.
c) The Parties agree that the Settlement Agreement constitutes full and final settlement of the present suit as well as full and final settlement of any claim or allegation by the Plaintiffs arising out of manufacture,
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above. The Order is downloaded from the DHC Server on 17/05/2025 at 13:11:48
CS(COMM) 792/2018 Page 1 of 3
import, marketing, use, sale, offer for sale, supply or other exploitation of ticagrelor products or any other product which is the subject matter of suit patents either by the Defendants or any person acting through or under the Defendants.
d) The Parties hereto state that they have no further claims or demands against each other and all the disputes and differences in this regard have been amicably settled.
e) The Parties further agree that they shall abide by the terms and conditions set out in the Settlement Agreement and shall not dispute the same hereinafter in future either themselves, or through any third parties.”
This is a digitally signed order.
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above. The Order is downloaded from the DHC Server on 17/05/2025 at 13:11:48
CS(COMM) 792/2018 Page 2 of 3
which are reproduced hereinabove.
CC(COMM) 24/2019, CC(COMM) 25/2019, CC(COMM) 26/2019
SAURABH BANERJEE, J
MAY 15, 2025/ bh
This is a digitally signed order.
The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above. The Order is downloaded from the DHC Server on 17/05/2025 at 13:11:48
CS(COMM) 792/2018 Page 3 of 3
1 issue framed by the court
Whether the joint application under Order XXIII Rule 3 CPC seeking a consent decree on settlement terms should be allowed.
1 provisions across 1 enactments
Astrazeneca AB
Anr
T Rao
Anr
Saurabh Banerjee
As recorded by the court registry
A suit of a commercial nature above the specified value, governed by the Commercial Courts Act 2015.
Judgements on the same questions, provisions and authorities, from every court
